Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
Glyceryl-o-tolyl ether |
EINECS | N/A |
CAS No. | 59-47-2 | Density | 1.152g/cm3 |
PSA | 49.69000 | LogP | 0.72700 |
Solubility | N/A | Melting Point |
69-71 °C(lit.) |
Formula | C10H14 O3 | Boiling Point |
153-154 °C4 mm Hg(lit.) |
Molecular Weight | 182.219 | Flash Point | 161.5°C |
Transport Information | N/A | Appearance | N/A |
Safety | Poison by intraperitoneal, intravenous, and subcutaneous routes. Moderately toxic by ingestion. When heated to decomposition it emits acrid smoke and irritating fumes. See also ETHERS. | Risk Codes | 22-36 |
Molecular Structure | Hazard Symbols | Xn | |
Synonyms |
1,2-Propanediol,3-(o-tolyloxy)- (8CI); (?à)-Mephenesin; 1,2-Dihydroxy-3-(2-methylphenoxy)propane;3-(2-Methylphenoxy)propane-1,2-diol; 3-(2-Tolyloxy)-1,2-propanediol;3-(o-Methylphenoxy)-1,2-propanediol; 3-(o-Tolyloxy)-1,2-propanediol;3-o-Toloxy-1,2-propanediol; Atensin; Avosyl; Avoxyl; BDH 312; Cresoxydiol;Cresoxypropanediol; Curythan; Daserd; Daserol; Decontractyl; Dioloxol; Glycerylo-tolyl ether; Glykresin; Glyotol; Kinavosyl; Lissephen; Memphenesin; Mephedan;Mephelor; Mephenesin; Mephenesine; Mephensin; Mepherol; Mephesin; Mephin;Mephson; Mervaldin; Myanesin; Myanol; Myasin; Mycocuran; Myodetensin;Myodetensine; Myolysin; Myopan; Myoserol; Myoten; Myoxane; NSC 25234; NSC36140; NSC 50788; NSC 8134; Oranixon; Prolax; RP 3602; Relaxar; Relaxil;Renarcol; Rhex; Sansdolor; Sinan; Spartoloxyn; Spasmolyn; Stilalgin; Thoxidil;Tolansin; Tolax; Tolcil; Tolhart; Tolosate; Toloxyn; Tolserol; Tolseron;Tolsin; Tolulexin; Tolulox; Tolyspaz; Walconesin; o-Cresyl glycerol ether;o-Cresyl a-glyceryl ether |
Article Data | 40 |
Conditions | Yield |
---|---|
With sodium hydroxide In N,N-dimethyl-formamide at 210℃; for 0.25h; Microwave irradiation; | 94% |
With sodium hydroxide In ethanol for 2h; Heating; | 79% |
With sodium hydroxide; water | |
With sodium ethanolate | |
With sodium ethanolate 1.) EtOH, RT, 30 min, 2.) EtOH, a) reflux, 4 h, b) RT, overnight; Yield given. Multistep reaction; |
Conditions | Yield |
---|---|
With tetrabutylammomium bromide; potassium carbonate; palladium dichloride In water at 60℃; for 5h; | 66% |
With tetrabutylammomium bromide; sodium hydroxide at 20℃; for 5h; | 0.7 g |
Conditions | Yield |
---|---|
With carbon dioxide; calcium oxide at 200℃; | |
With sodium acetate at 200 - 210℃; | |
With potassium carbonate; Diethyl carbonate at 105 - 110℃; for 28h; | 76 %Spectr. |
Etherification; | |
sodium hydroxide Etherification; |
Conditions | Yield |
---|---|
With water | |
With ethanol |
Conditions | Yield |
---|---|
With sulfuric acid for 1h; Ambient temperature; | |
With water at 25℃; pH=7.2; Microbiological reaction; Enzymatic reaction; enantioselective reaction; |
Acetic acid 1-acetoxymethyl-2-o-tolyloxy-ethyl ester
mephenesin
Conditions | Yield |
---|---|
With sodium hydroxide In isopropyl alcohol at 85℃; Hydrolysis; | 20 mg |
Conditions | Yield |
---|---|
With water Erhitzen des Reaktionsprodukts mit wss. Na2CO3; |
1-chloro-3-(2-methylphenoxy)propan-2-ol
mephenesin
Conditions | Yield |
---|---|
Multi-step reaction with 3 steps 1: 231 mg / NaH / ethyl acetate; hexane / 0.08 h 2: 100 - 110 °C 3: 20 mg / aq. NaOH / propan-2-ol / 85 °C View Scheme |
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: 100 - 110 °C 2: 20 mg / aq. NaOH / propan-2-ol / 85 °C View Scheme |
Conditions | Yield |
---|---|
Multi-step reaction with 4 steps 1: aq. NaOH / propan-2-ol / 84 °C 2: 231 mg / NaH / ethyl acetate; hexane / 0.08 h 3: 100 - 110 °C 4: 20 mg / aq. NaOH / propan-2-ol / 85 °C View Scheme |
IUPAC Name: 3-(2-Methylphenoxy)propane-1,2-diol
Synonyms of Glyceryl-o-tolyl ether (CAS NO.59-47-2): 1,2-Dihydroxy-3-(2-methylphenoxy)propane ; 1-Ortho-tolylglycerol ether ; 1-o-Tolylglycerol ether ; 3-(2-Methylphenoxy)-1,2-propanediol ; 3-(2-Tolyloxy)-1,2-propanediol ; 3-(o-Methylphenoxy)-1,2-propanediol ; 3-(o-Tolyloxy)propane-1,2-diol ; 3-o-Toloxy-1,2-propanediol 4-06-00-01952 (Beilstein Handbook Reference) ; alpha,beta-Dihydroxy-gamma-(2-methylphenoxy)propane ; alpha-(o-Tolyl)glyceryl ether ; o-Cresol glyceryl ether ; o-Cresyl alpha-glyceryl ether ; o-Cresyl glycerol ether ; o-Kresol-glycerinaether ; o-Kresol-glycerinaether [German] ;
CAS NO: 59-47-2
Molecular Formula of Glyceryl-o-tolyl ether (CAS NO.59-47-2): C10H14O3
Molecular Weight: 182.2164
H bond acceptors: 3
H bond donors: 2
Freely Rotating Bonds: 6
Polar Surface Area: 27.69 Å2
Index of Refraction: 1.545
Molar Refractivity: 50.05 cm3
Molar Volume: 158.1 cm3
Surface Tension: 46.1 dyne/cm
Density: 1.152 g/cm3
Flash Point: 161.5 °C
Enthalpy of Vaporization: 58.26 kJ/mol
Boiling Point: 310.9 °C at 760 mmHg
Vapour Pressure: 0.000249 mmHg at 25°C
Molecular Structure:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
hamster | LD50 | intraperitoneal | 322mg/kg (322mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: MUSCLE WEAKNESS BEHAVIORAL: ATAXIA | Journal of Pharmacology and Experimental Therapeutics. Vol. 129, Pg. 75, 1960. |
hamster | LD50 | oral | 821mg/kg (821mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: MUSCLE WEAKNESS BEHAVIORAL: ATAXIA | Journal of Pharmacology and Experimental Therapeutics. Vol. 129, Pg. 75, 1960. |
mouse | LD50 | intraperitoneal | 320mg/kg (320mg/kg) | Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 55, Pg. 1272, 1959. | |
mouse | LD50 | intravenous | 175mg/kg (175mg/kg) | Comptes Rendus Hebdomadaires des Seances, Academie des Sciences. Vol. 248, Pg. 3642, 1959. | |
mouse | LD50 | oral | 720mg/kg (720mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 17, Pg. 242, 1967. | |
mouse | LD50 | subcutaneous | 285mg/kg (285mg/kg) | BEHAVIORAL: ANTICONVULSANT | Acta Pharmacologica et Toxicologica. Vol. 19, Pg. 247, 1962. |
rabbit | LD50 | intravenous | 125mg/kg (125mg/kg) | SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE BEHAVIORAL: REGIDITY BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) | International Journal of Neuropharmacology. Vol. 5, Pg. 305, 1966. |
rabbit | LDLo | oral | 2300mg/kg (2300mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 89, Pg. 145, 1952. |
rat | LD50 | intraperitoneal | 283mg/kg (283mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: MUSCLE WEAKNESS BEHAVIORAL: ATAXIA | Journal of Pharmacology and Experimental Therapeutics. Vol. 129, Pg. 75, 1960. |
rat | LD50 | intravenous | 133mg/kg (133mg/kg) | BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: DYSPNEA KIDNEY, URETER, AND BLADDER: HEMATURIA | Proceedings of the Society for Experimental Biology and Medicine. Vol. 85, Pg. 323, 1954. |
rat | LD50 | oral | 625mg/kg (625mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: ANTIPSYCHOTIC LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 130, Pg. 280, 1961. |
Hazard Codes of Glyceryl-o-tolyl ether (CAS NO.59-47-2): Xn
Risk Statements: 22-36
R22: Harmful if swallowed. R36: Irritating to eyes.
Safety Statements: 26
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
WGK Germany: 2
RTECS: TZ1225000